在SERENA-6試驗中，卡美司群聯合療法使伴有ESR1腫瘤突變的晚期HR陽性乳癌患者的首次疾病進展時間延遲了55%，第二次疾病進展時間延遲了37%。
2026年6月2日－III期SERENA-6試驗的進一步正面結果顯示，阿斯特捷利康的卡美司群聯合細胞週期蛋白依賴性激酶（CDK）4/6抑制劑－帕博西尼、瑞博西尼或阿貝西利－維持了其…
该文章暂未提取到完整正文，已从资讯列表和商品关联资讯中自动隐藏。你可以返回文章列表继续浏览其他内容。
文章相關商品
系統已根據文章標題、摘要和正文，自動匹配目前在售的強相關藥品。
常見問題
Which products are related to this article?
The system matched these relevant products from the article content: 盧修斯 帕博西尼 Palbociclib 在線購買.
How can I view the medicines discussed in this article?
Use the related product cards below the article to review available specifications, prices, product information, and reviews.
Does this article replace advice from a doctor or pharmacist?
No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.
